Spectrum Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Spectrum Pharmaceuticals

11/08/2022 14:33

* Spectrum Pharmaceuticals Inc  SPPI.OQ  reported a
quarterly
adjusted loss of 17 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 16 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Spectrum Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 17 cents​.
    * The mean earnings estimate of analysts had risen by
about 11.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Spectrum Pharmaceuticals Inc shares had risen by 43.6%
this
quarter and lost 11.8% so far this year.
    * The company reported a quarterly loss of $29.05 million.
    * Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 01:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.16          -0.17          Missed
 Mar. 31 2022      -0.19          -0.08          Beat
 Dec. 31 2021      -0.21          -0.26          Missed
 Sep. 30 2021      -0.28          -0.21          Beat